The below posters presented at AIBC 2022 can be viewed onsite in 2 shifts.
Shift 1: P01-P37
Posters should be mounted between 17:00-17:30 on Thursday, October 13 and removed by 13:00 on Friday, October 14.
| Breast imaging | |
| P01 |
DEVELOPMENT OF A CELL-SENSITIVE ELASTOGRAPHY MODEL TO DETECT ULTRA-SMALL BREAST CANCERS |
| P02 |
PET SCANS FOR LOCALLY ADVANCED BREAST CANCER AND DIAGNOSTIC MRI TO DETERMINE THE EXTENT OF OPERATION AND RADIOTHERAPY (TROG 12.02 PET LABRADOR) |
| P03 | THE APPEARANCE OF FAT NECROSIS ON CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY Natalia Garibotto, Australia |
| P04 | INJECTION MAMMOPLASTY: NORMAL IMAGING APPEARANCES AND IMPLICATIONS FOR MAMMOGRAPHIC SCREENING Winfred Xi Tai Goh, Singapore |
| P05 | RELATIONSHIP BETWEEN PATIENT AGE, MAMMOGRAPHIC BREAST DENSITY AND BACKGROUND PARENCHYMAL ENHANCEMENT ON CONTRAST-ENHANCED MAMMOGRAPHY Yen Huynh, Australia |
| P06 | CASE DIFFICULTY AS EVALUATED BY BREAST PHYSICIANS AND RADIOLOGISTS: DATA FROM THE BREAST MAMMOGRAM TEST SETS Sarah Lewis, Australia |
| P07 | BENEFITS OF BREAST TOMOSYNTHESIS IN BREASTSCREEN ASSESSMENT CLINICS Daniel Liu, Australia |
| P08 | BREAST BIOPSY PRACTICE AND BREAST BIOPSY MARKER UTILISATION: AUSTRALIAN AND NEW ZEALAND PERSPECTIVE Rose Radic, Australia |
| P09 | BREAST BIOPSY MARKER COST AND AVAILABILITY INFLUENCES UTILISATION IN RADIOLOGY PRACTICE Rose Radic, Australia |
| P10 | CLINICALLY AND RADIOLOGICALLY OCCULT PAGET’S DISEASE OF THE BREAST: A 14-YEAR RETROSPECTIVE CASE SERIES AT A SINGLE TERTIARY INSTITUTION Ananda Kallyani S.M. Ponniah, Australia |
| DCIS | |
| P11 | LOCAL RECURRENCE IN DCIS TREATED PREDOMINANTLY WITHOUT RADIATION Christina Kozul, Australia |
| P12 | BREAST SURGEONS’ VIEWS ON ENDOCRINE THERAPY FOR TREATMENT OF DUCTAL CARCINOMA IN SITU Ben Lancashire, Australia |
| P13 | ENDOCRINE THERAPY FOR TREATMENT OF DUCTAL CARCINOMA IN SITU – A CASE FOR RESEARCH IN THE AUSTRALIAN AND NEW ZEALAND SETTING Ben Lancashire, Australia |
| P14 | NOTORIOUS DCIS WITH LOBULAR CANCERIZATION, MULTIPLE RECURRENCES AND CONTRALATERAL AXILLARY METASTASES(CAM) – A CASE REPORT Swathi Prakash, India |
| HER2 positive breast cancer | |
| P15 |
PIPPA: A PROSPECTIVE OBSERVATIONAL STUDY OF MOBILE APP-BASED PATIENT-REPORTED OUTCOMES IN PATIENTS TREATED WITH PALBOCICLIB FOR ADVANCED BREAST CANCER IN AUSTRALIA |
| Locoregional therapy | |
| P16 | OUTCOMES OF AXILLARY CLEARANCE FOR POSITIVE MACROSCOPIC SENTINEL NODE BIOPSY IN BREAST CANCER, A REGIONAL CENTRE EXPERIENCE Maxwell Jambor, Australia |
|
Medical oncology |
|
| P17 |
SYNCHRONOUS OPERABLE PANCREATIC AND BREAST CANCER WITHOUT GENETIC MUTATION: A LITERATURE REVIEW AND DISCUSSION |
| Molecular assays | |
| P18 | OPTIMA, A PROSPECTIVE INTERNATIONAL RANDOMIZED TRIAL TO VALIDATE THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF GENE EXPRESSION TEST-DIRECTED CHEMOTHERAPY IN HIGH CLINICAL RISK EARLY BREAST CANCER Janet Dunn, Australia |
| Neoadjuvant therapy | |
| P19 | NEOADJUVANT CHEMOTHERAPY UTILISATION AND OUTCOMES IN BREAST CANCER PATIENTS AT A TERTIARY HOSPITAL IN NORTH QUEENSLAND Tony Mallett, Australia |
| Pathology | |
| P20 | PARANEOPLASTIC CHOREA SECONDARY TO INVASIVE CARCINOMA OF THE BREAST: A CASE REPORT Ali Hooshyari, New Zealand |
| P21 | WARFARIN INDUCED BREAST NECROSIS: CASE REPORT Vaishnaivy Mahendravarman, Australia |
| P22 | COMPARISON OF BREAST CANCER HER2 STATUS TESTING WITH IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDISATION Aswin Shanmugalingam, Australia |
| Prevention | |
| P23 | DEVELOPING ALTERNATIVE PREVENTION STRATEGIES: CAN COLLEGE STUDENTS HAVE AN IMPACT ON BREAST CANCER SCREENING? Adam Johnson, United States |
| Radiation oncology | |
| P24 | A RETROSPECTIVE AUDIT OF DOSE AND LOCAL CONTROL IN POST-MASTECTOMY BREAST CANCER PATIENTS. IS STANDARD BOLUS REQUIRED WITH CONTEMPORARY IMRT/VMAT TREATMENT PLANNING? Susan Carroll, Australia |
| P25 | A REVIEW OF WOMEN WITH A SOLITARY EXTRACRANIAL METASTASIS FROM BREAST CANCER Patrick Dyer, Australia |
| P26 | ACUTE TOXICITY IN ADJUVANT BREAST RADIOTHERAPY USING KNOWLEDGE-BASED VOLUMETRIC MODULATED ARC THERAPY PLANNING Alexandra Knight, Australia |
| P27 | INTERIM ANALYSIS OF THE PREDICT REGISTRY AUSTRALIA: CHANGES IN TREATMENT RECOMMENDATION FOR A BIOLOGIC SIGNATURE PREDICTIVE OF RADIATION THERAPY (RT) BENEFIT IN PATIENTS WITH DCIS Yvonne Zissiadis, Australia |
| P28 | INTRAOPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER: EARLY EXPERIENCE AND QUALITY OF LIFE OUTCOMES FROM A WESTERN AUSTRALIAN REGISTRY Yvonne Zissiadis, Australia |
| Reconstruction | |
| P29 | AUTOLOGOUS VERSUS IMPLANT-BASED BREAST RECONSTRUCTION: IMPACT OF SCAR QUALITY (SCAR-Q) IN BREAST AND ABDOMINAL SCARRING AND QUALITY OF LIFE (BREAST-Q) FOLLOWING BREAST RECONSTRUCTION Nirmal Dayaratna, Australia |
| P30 | PROSPECTIVE EVALUATION OF ROBOTIC-ASSISTED DEEP INFERIOR ARTERY PERFORATOR (DIEP) FLAP HARVEST IN BREAST RECONSTRUCTION Nirmal Dayaratna, Australia |
| P31 | TREATMENT OF COMPLEX BREAST WOUNDS WITH PLATELET RICH FIBRIN Gagandip Sanghera, Australia |
| P32 | BREAST IMPLANT ASSOCIATED – ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSIS AND MANAGEMENT – CASE SERIES Gagandip Sanghera, Australia |
| P33 | CARBON DIOXIDE VS. SALINE TISSUE EXPANDERS FOR BREAST RECONSTRUCTION – LITERATURE REVIEW AND CURRENT PRACTICE Gagandip Sanghera, Australia |
| P34 | PATTERNS OF BREAST RECONSTRUCTION AND THE INFLUENCE OF A SURGICAL MULTIDISCIPLINARY CLINIC Yuan Tian, Australia |
| P35 | 3D BREAST SCAFFOLD RECONSTRUCTION: A PRECLINICAL ANIMAL MODEL Clement Wong, Australia |
| Screening | |
| P36 | BENEFITS VERSUS HARMS OF BREAST CANCER SCREENING REVISITED: A LARGE, RETROSPECTIVE COHORT STUDY QUANTIFYING ADDITIONAL TREATMENT ASSOCIATED WITH LATER DIAGNOSIS IN AUSTRALIA AND NEW ZEALAND Kathy Dempsey, Australia |
| Triple negative breast cancer | |
| P37 | INVESTIGATING THE ROLE OF BANF1 IN TNBC Maddison Rose, Australia |
Shift 2: P38-P76
Posters should be mounted between 14:00-14:30 on Friday, October 14 and removed by 14:00 on Saturday, October 15.
| Surgery | |
| P38 | REGIONAL BLOCK VS WOUND INFILTRATION OF LOCAL ANAESTHETIC IN ONCOLOGICAL BREAST SURGERY – A SYSTEMATIC REVIEW AND META-ANALYSIS Tess Asgill, Australia |
| P39 | OUTCOMES FOLLOWING RE-EXCISION OF MARGINS FOR LOBULAR BREAST CANCERS AFTER BREAST CONSERVING SURGERY- REFLECTIONS FROM THE BREASTSURGANZ QUALITY AUDIT Philip Britten-Jones, Australia |
| P40 | DIFFERENCES IN BREAST CANCER SURGERY IN INDIGENOUS AND NON-INDIGENOUS WOMEN IN AUSTRALIA Nirmal Dayaratna, Australia |
| P41 | PERCEPTION OF UPPER CHEST CHEMOTHERAPY PORT (PORT-A-CATH) SCARRING IN BREAST RECONSTRUCTION AND MASTECTOMY PATIENTS Nirmal Dayaratna, Australia |
| P42 | ATNEC: A RANDOMIZED TRIAL INVESTIGATING WHETHER AXILLARY TREATMENT CAN BE AVOIDED IN T1-3N1M0 BREAST CANCER PATIENTS WITH NO RESIDUAL CANCER IN THE AXILLARY NODES AFTER NEOADJUVANT CHEMOTHERAPY Janet Dunn, United Kingdom |
| P43 | WHAT’S THE ATTRACTION – MAGTRACE AS AN ALTERNATIVE TO LYMPHOSPHINGRAPHY IN SENTINAL NODE BIOPSY IN BREAST CANCER Megan Emonson, Australia |
| P44 | LOCAL BREAST CANCER RECURRENCE FOLLOWING AUTOLOGOUS RECONSTRUCTION: CLINICAL AND RADIOLOGICAL CHALLENGES RELATING TO SURVEILLANCE Cheng Feng, Australia |
| P45 | SYSTEMATIC REVIEW OF LONG THORACIC NERVE INJURY IN BREAST CANCER AXILLARY SURGERY Natalia Garibotto, Australia |
| P46 | DE-ESCALATING AXILLARY SURGERY IN BREAST CANCER: TARGETED AXILLARY DISSECTION. OUR EXPERIENCE AT THE ROYAL PERTH AND FIONA STANLEY HOSPITALS, WESTERN AUSTRALIA Ji Gu, Australia |
| P47 | CHYLE LEAK POST MASTECTOMY AND AXILLARY CLEARANCE: A RARE BUT CHALLENGING COMPLICATION Ji Gu, Australia |
| P48 | PATIENT REPORTED OUTCOME MEASURES AFTER BREAST AUGMENTATION – USING THE BREAST-Q IS Randi Jayasinghe, Australia |
| P49 | INTRAOPERATIVE SENTINEL NODE ANALYSIS USING TOUCH IMPRINT CYTOLOGY – A WESTERN AUSTRALIAN EXPERIENCE OF DIAGNOSTIC ACCURACY IN 779 PATIENTS WITH BREAST CANCER Anitha Karunairajah, Australia |
| P50 | BORDER REOPENING AND COVID-19 PREPARATION: IMPACT ON BREAST CANCER HEALTHCARE PROVISION FROM A WEST AUSTRALIAN PERSPECTIVE Thomas England, Australia |
| P51 | LEARNING CURVE AND SURGICAL OUTCOMES FOLLOWING INTRODUCTION OF RADIO-GUIDED OCCULT LESION LOCALISATION USING IODINE-125 SEEDS (ROLLIS) AT A TERTIARY BREAST UNIT David Lim, Australia |
| P52 | COMPLICATIONS OF INJECTABLE BREAST AUGMENTATION 21 YEARS LATER Oscar Brett, Australia |
| P53 | OUTCOMES AFTER RADIOACTIVE 125-IODINE SEED LOCALISATION FOR IMPALPABLE IN SITU AND INVASIVE BREAST CANCER: THE EARLY EXPERIENCE Tony Mallett, Australia |
| P54 | A DISSECTION STUDY OF THE GROSS ANATOMY OF THE ATTACHMENTS OF THE FEMALE BREAST TO THE CHEST WALL Deirdre McGhee, Australia |
| P55 | ALTERNATIVE LOCALISATION METHOD FOR NON-PALPABLE BREAST CANCER: AUDIT OF RE-EXCISION RATES MAGSEED® LOCALIZATION OF NON-PALPABLE BREAST CANCERS IN AN AUSTRALIAN REGIONAL NON-TERTIARY HOSPITAL Su Su Naing, Australia |
| P56 | OCCULT BREAST CANCER: WHERE ARE WE AT? Adam Ofri, Australia |
| P57 | DIAGNOSIS AND MANAGEMENT OF PHYLLODES TUMOURS FOR THE SURGEON: AN ALGORITHM Adam Ofri, Australia |
| P58 | THE LIMBERG FLAP IN MASTECTOMY T-JUNCTION NECROSIS: AN UNDERUTILISED TECHNIQUE Adam Ofri, Australia |
| P59 | OLDER BREAST CANCER: A DEDICATED SENTINEL LYMPH NODE METASTASIS NOMOGRAM Adam Ofri, Australia |
| P60 | BREAST SURGERY IN A TEACHING PUBLIC HOSPITAL: DOES TRAINING INCREASE COMPLICATION RATES Adam Ofri, Australia |
| P61 | OLDER BREAST CANCER: NOT ALL T1 HR+ BREAST CANCERS ARE EQUAL Adam Ofri, Australia |
| P62 | OLDER BREAST CANCER IN AUSTRALIA: TUMOUR CHARACTERISTICS OF SCREENED VERSUS SYMPTOMATIC BREAST CANCERS Adam Ofri, Australia |
| P63 | BREAST SURGERY IN A TEACHING PUBLIC HOSPITAL: DOES ONCOPLASTIC TRAINING SIGNIFICANTLY IMPACT SURGICAL DURATION Adam Ofri, Australia |
| P64 | SKIN SPARING MASTECTOMY(SSM) WITH TOTAL AUTOLOGOUS FAT GRAFTING WITH PLATELET-RICH-PLASMA(PrP) VERSUS BREAST CONSERVATION THERAPY(BCS) IN EARLY BREAST CANCER(EBC) PATIENTS: RANDOMISED CONTROLLED TRIAL(RCT) WITH FOLLOW-UP OF 34 MONTHS Swathi Prakash, India |
| P65 | SENTINEL LYMPH NODE BIOPSY UNDER LOCAL ANAESTHESIA EFFECTIVE AND FEASIBLE – A 5-YEAR EXPERIENCE IN A TERTIARY CARE CENTER IN INDIA Vandhana Rajgopal, India |
| P66 | THE EVOLUTION OF MAGSEED™ LOCALIZATION IN THE MANAGEMENT OF IMPALPABLE BREAST CANCERS Syed Ali Abbas Rizvi, Australia |
| P67 | SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION (ALND) Nikolaos S. Salemis, Greece |
| P68 | MICROPOROUS POLYSACCHARIDE HEMOSPHERES (MPH) AND SEROMA FORMATION AFTER MASTECTOMY AND SENTINEL NODE BIOPSY – A PROSPECTIVE RANDOMISED CLINICAL TRIAL Gagandip Sanghera, Australia |
| P69 | HISTORY AND EVOLUTION OF SENTINEL LYMPH NODE MAPPING Gagandip Sanghera, Australia |
| P70 | REVIEW OF MANAGEMENT AND OUTCOMES OF BORDERLINE AND MALIGNANT PHYLLODES TUMOURS OF THE BREAST AT A UK TERTIARY CENTRE Gausihi Sivarajah, Australia |
| P71 | BREAST FIBROMATOSIS: 2000 TO THE PRESENT Mike Wu, Australia |
| Survivorship | |
| P72 | HOW THINK PINK FOUNDATION OVERCAME COVID-19 LOCKDOWNS AND FLOURISHED DURING THE PANDEMIC Andrea Cannon, Australia |
| P73 | MALE BREAST CANCER: A SINGAPORE PERSPECTIVE Joshua Sheng Hao Lim, Singapore |
| P74 | BREAST CANCER SURVIVORSHIP CLINIC: A PILOT STUDY Ananda Kallyani S.M. Ponniah, Australia |
| Symptom Management | |
| P75 | COVID-19: A RISK FACTOR FOR RECURRENT BREAST IMPLANT-RELATED SEROMA? Diana Tam, Australia |
| P76 | REACH, ACCEPTABILITY, USEFULNESS AND ENGAGEMENT WITH A HEALTH SUPPORT PROGRAM FOR BREAST CANCER SURVIVORS DELIVERED VIA TEXT MESSAGES: A MIXED-METHODS EVALUATION OF THE EMPOWER-SMS RANDOMISED CONTROLLED TRIAL Anna C. Singleton, Australia |